Neoadjuvant Gemcitabine and Cisplatin Plus Atezolizumab in Patients With Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
J. Clin. Oncol 2022 Jan 28;[EPub Ahead of Print], SA Funt, M Lattanzi, K Whiting, H Al-Ahmadie, C Quinlan, MY Teo, CH Lee, D Aggen, D Zimmerman, D McHugh, A Apollo, TD Durdin, H Truong, J Kamradt, M Khalil, B Lash, I Ostrovnaya, AS McCoy, G Hettich, A Regazzi, M Jihad, N Ratna, A Boswell, K Francese, Y Yang, E Folefac, HW Herr, SM Donat, E Pietzak, EK Cha, TF Donahue, AC Goh, WC Huang, DF Bajorin, G Iyer, BH Bochner, AV Balar, A Mortazavi, JE RosenbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.